Bibliography
ATS, American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am. J. Respir. Crit. Care Med., 2000. 161: p. 646–64.
Mason, R., et al., NHLBI Workshop Summary. Pharmacological therapy for idiopathic pulmonary fibrosis. Past, present, and future. Am J Respir Crit Care Med, 1999. 160(5): p. 1771–1777.
Monaghan, H., et al., Prognostic implications of histologic patterns in multiple surgical lung biopsies from patients with idiopathic interstitial pneumonias. Chest, 2004. 125(2): p. 522–526.
Moodley, Y., et al., Fibroblasts isolated from normal lungs and those with idiopathic pulmonary fibrosis differ in interleukin-6/gp130-mediated cell signaling and proliferation. Am J Pathol., 2003a. 163(1): p. 345–354.
Moodley, Y., et al., Inverse effects of interleukin-6 on apoptosis of fibroblasts from pulmonary fibrosis and normal lungs. Am J Respir Cell Mol Biol, 2003b. 29(4): p. 490–498.
Kishimoto, T., et al., Interleukin-6 family of cytokines and gp130. Blood, 1995. 86(4): p. 1243–1254.
Heinrich, P., et al., Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem J, 1998. 334(2): p. 297–314.
Ernst, M., et al., Defective gp130-mediated signal transducer and activator of transcription (STAT) signaling results in degenerative joint disease, gastrointestinal ulceration, and failure of uterine implantation. J Exp Med, 2001. 194(2): p. 189–203.
Pantelidis, P., et al., Analysis of tumor necrosis factoralpha, lymphotoxin-alpha, tumor necrosis factor receptor II, and interleukin-6 polymorphisms in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med, 2001. 163(6): p. 1432–1436.
Epperly, M.W., et al., Bone marrow origin of myofibroblasts in irradiation pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol., 2003. 29(2): p. 213–224.
Hashimoto, N., et al., Bone marrow-derived progenitor cells in pulmonary fibrosis. J Clin Invest, 2004. 113(2): p. 243–252.
Becker, C., et al., TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 transsignaling. Immunity, 2004. 21(4): p. 491–501.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
O’Donoghue, R.J.J., Anderson, G.P., Bozinovski, S. et al. Directed Gp130-Mediated Signaling Dissociates Inflammation from Fibrosis in Bleomycin Induced Lung Injury. Inflamm. Res. 54 (Suppl 2), S215–S216 (2005). https://doi.org/10.1007/BF03354054
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03354054